These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3127216)

  • 1. Mitomycin C-induced renal toxicity, a dose-dependent side effect?
    Verwey J; de Vries J; Pinedo HM
    Eur J Cancer Clin Oncol; 1987 Feb; 23(2):195-9. PubMed ID: 3127216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study on the dose relationship of mitomycin C-induced interstitial pneumonitis.
    Verweij J; van Zanten T; Souren T; Golding R; Pinedo HM
    Cancer; 1987 Aug; 60(4):756-61. PubMed ID: 3109726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitomycin C-induced hemolytic uremic syndrome. Six case reports and review of the literature on renal, pulmonary and cardiac side effects of the drug.
    Verweij J; van der Burg ME; Pinedo HM
    Radiother Oncol; 1987 Jan; 8(1):33-41. PubMed ID: 3101142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study on the dose dependency of cardiotoxicity induced by mitomycin C.
    Verweij J; Funke-Küpper AJ; Teule GJ; Pinedo HM
    Med Oncol Tumor Pharmacother; 1988; 5(3):159-63. PubMed ID: 3137399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal complications of mitomycin C therapy with special reference to the total dose.
    Valavaara R; Nordman E
    Cancer; 1985 Jan; 55(1):47-50. PubMed ID: 3917353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery from mitomycin C-induced hemolytic uremic syndrome. A case report.
    Verwey J; Boven E; van der Meulen J; Pinedo HM
    Cancer; 1984 Dec; 54(12):2878-81. PubMed ID: 6437662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry.
    Lesesne JB; Rothschild N; Erickson B; Korec S; Sisk R; Keller J; Arbus M; Woolley PV; Chiazze L; Schein PS
    J Clin Oncol; 1989 Jun; 7(6):781-9. PubMed ID: 2497229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of mitomycin C-associated hemolytic uremic syndrome by plasmapheresis.
    Garibotto G; Acquarone N; Saffioti S; Deferrari G; Villaggio B; Ferrario F
    Nephron; 1989; 51(3):409-12. PubMed ID: 2493141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal toxicity of mitomycin-C.
    Ravikumar TS; Sibley R; Reed K; Grage TB
    Am J Clin Oncol; 1984 Jun; 7(3):279-85. PubMed ID: 6428215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoma-associated hemolytic-uremic syndrome in a patient receiving 5-fluorouracil-adriamycin-mitomycin C combination chemotherapy.
    Mergenthaler HG; Binsack T; Wilmanns W
    Oncology; 1988; 45(1):11-4. PubMed ID: 3124028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitomycin-C nephrotoxicity: a clinico-pathologic study of 17 cases.
    Giroux L; Bettez P; Giroux L
    Am J Kidney Dis; 1985 Jul; 6(1):28-39. PubMed ID: 3927715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I and pharmacologic study of BMS-181174 given as a 6 h infusion every 4 weeks to patients with advanced solid tumors.
    Planting AS; Schellens JH; van der Burg ME; de Boer-Dennert M; Winograd B; Stoter G; Verweij J
    Anticancer Drugs; 1999 Oct; 10(9):821-7. PubMed ID: 10587292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nephrotoxicity of mitomycin C (apropos of 25 case reports). Results of a multicenter survey organized by the Society of Nephrology].
    Cordonnier D; Vert-Pré FC; Bayle F; Alix JL; Couderc P
    Nephrologie; 1985; 6(1):19-26. PubMed ID: 3923381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy-induced hemolytic uremic syndrome. A complication to mitomycin treatment of breast carcinoma].
    Schjølseth SA; Hagen T; Ottestad L; Jakobsen E
    Tidsskr Nor Laegeforen; 1995 Nov; 115(27):3371-3. PubMed ID: 7491579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Uremic hemolytic syndrome induced by mitomycin C. Presentation of a series of 5 cases and review of the literature].
    Nicolás JM; Villalta J; González-Clemente JM; Antúnez E; Almirall J; Bosch J; Torras A; Urbano-Márquez A
    Rev Clin Esp; 1990 Mar; 186(4):166-70. PubMed ID: 2114657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemolytic-uremic syndrome caused by mitomycin C].
    de Insausti CL; Gutiérrez LE
    Sangre (Barc); 1988 Aug; 33(4):319-20. PubMed ID: 3142062
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pneumo-renal syndrome with thrombotic microangiopathy after treatment with mitomycin].
    Larregain Fournier D; Arlet P; Durand D; Fournier D; Le Tallec Y
    Presse Med; 1985 Apr; 14(15):842. PubMed ID: 3158910
    [No Abstract]   [Full Text] [Related]  

  • 18. [A case report of hemolytic uremic syndrome (HUS) induced by antineoplastic agents].
    Anai H; Okada Y; Okubo K; Korenaga D; Maehara Y; Sugimachi K; Ohi Y
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1487-91. PubMed ID: 2120375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolytic-uremic syndrome after cancer chemotherapy without mitomycin C.
    Desablens B; Fievet P; Pruna A; Claisse JF; Westeel PF; Tolani M; Fournier A
    Nephron; 1986; 42(4):343-4. PubMed ID: 3083278
    [No Abstract]   [Full Text] [Related]  

  • 20. Mitomycin C associated hemolytic uremic syndrome.
    Jain S; Seymour AE
    Pathology; 1987 Jan; 19(1):58-61. PubMed ID: 3108839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.